COVID-19 (SARS-CoV-2 infection) Infections and Infestations COVID-19 (SARS-CoV-2 infection)
Conditions
Interventions
Observational study: using the British Paediatric Surveillance Unit system we will collect information about presentation, mode of transmission, severity, management and outcomes for hospitalised neon
Sponsors
University of Oxford
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Two groups of babies are eligible for inclusion: 1. Babies who have a diagnosis of SARS-CoV-2 infection made on a sample taken in the first 28 days and received inpatient care on a postnatal ward, neonatal unit, paediatric inpatient ward or paediatric intensive care unit 2. Babies born to mothers with COVID-19 where the baby requires hospital care within the first 28 days after birth
Exclusion criteria
Exclusion criteria: Does not meet inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of neonatal COVID-19 and mode of transmission measured using patient records from the British Paediatric Surveillance Unit system from 1st March 2020 until 31st March 2021 | — |
Secondary
| Measure | Time frame |
|---|---|
| Measured using patient records from the British Paediatric Surveillance Unit system from 1st March 2020 until 31st March 2021: 1. Presentation natural history and clinical presentation of neonatal hospitalised SARS-CoV-2 2. Presentation of neonates hospitalised whose mothers have COVID-19 3. Management, clinical treatment and outcomes of hospitalised neonates with SARS-CoV-2 4. Management, clinical treatment and outcomes of hospitalised neonates with SARS-CoV-2 5. Management, clinical treatment and outcomes of hospitalised neonates with SARS-CoV-2 6. Management, clinical treatment and outcomes of hospitalised neonates born to mothers with COVID-1 | — |
Countries
England, United Kingdom
Outcome results
None listed